Nitrofurantoin and Fosfomycin, effective oral empirical treatment options against multidrug resistant Escherichia coli
The present study is designed to monitor antibiotic susceptibility pattern of Escherichia coli to assist in forecasting empirical therapy of urinary tract infection.
It is a retrospective cross sectional study. It was carried out at Dow Diagnostic Research and Reference Laboratory for a period of 3 months from February 2017 to April 2017. A data of total 5000 urine culture and sensitivity test reports was taken from the medical record. The data was analyzed by SPSS version 16.
Out of 5000 urine samples processed, 1565 showed significant bacterial growth. Escherichia coli was the most common pathogen isolated. Meropenem, Amikacin, Fosfomycin and Nitrofurantoin respectively were found to be the most sensitive antibiotics against Escherichia coli.
Fosfomycin and Nitrofurantoin are effective oral antibiotics against Escherichia coli causing urinary tract infection. The present study may help clinicians in making rational choice of empirical treatment of the patients.
2. Schappert SM, Rechsteiner EA. Ambulatory medical care utilization estimates for 2006. 2008.
3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. The American journal of medicine. 2002;113(1):5-13.
4. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Annals of epidemiology. 2000;10(8):509-15.
5. Olowe O, Ojo-Johnson B, Makanjuola O, Olowe R, Mabayoje V. Detection of bacteriuria among human immunodeficiency virus seropositive individuals in Osogbo, south-western Nigeria. European Journal of Microbiology and Immunology. 2015;5(1):126-30.
6. Shaifali I, Gupta U, Mahmood SE, Ahmed J. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. North American journal of medical sciences. 2012;4(4):163.
7. Gardiner BJ, Stewardson AJ, Abbott IJ, Peleg AY. Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems. Australian prescriber. 2019;42(1):14.
8. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical infectious diseases. 2011;52(5):e103-e20.
9. Khan MI, Xu S, Ali MM, Ali R, Kazmi A, Akhtar N, et al. Assessment of multidrug resistance in bacterial isolates from urinary tract-infected patients. Journal of Radiation Research and Applied Sciences. 2020;13(1):267-75.
10. Ullah A, Shah SRH, Almugadam BS, Sadiqui S. Prevalence of symptomatic urinary tract infections and antimicrobial susceptibility patterns of isolated uropathogens in kohat region of Pakistan. MOJ Biol Med. 2018;3(4):85-9.
11. Bitew A, Molalign T, Chanie M. Species distribution and antibiotic susceptibility profile of bacterial uropathogens among patients complaining urinary tract infections. BMC infectious diseases. 2017;17(1):1-8.
12. Yadav M, Pal R, Damrolien S, Khumanthem SD. Microbial spectrum of urinary tract infections and its antibiogram in a tertiary care hospital. Int J Res Med Sci. 2017;5(6):2718-22.
13. Khan IU, Mirza IA, Ikram A, Afzal A, Ali S, Hussain A, et al. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection. Journal of the College of Physicians and Surgeons Pakistan. 2014;24(11):840-4.
14. Al-Zahrani J, Al Dossari K, Gabr AH, Ahmed A-f, Al Shahrani SA, Al-Ghamdi S. Antimicrobial resistance patterns of Uropathogens isolated from adult women with acute uncomplicated cystitis. BMC microbiology. 2019;19(1):237.
15. Pouladfar G, Basiratnia M, Anvarinejad M, Abbasi P, Amirmoezi F, Zare S. The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz. Medicine. 2017;96(37).
16. Demir M, Kazanasmaz H. Uropathogens and antibiotic resistance in the community and hospital-induced urinary tract infected children. Journal of Global Antimicrobial Resistance. 2020;20:68-73.
17. Prasada S, Bhat A, Bhat S, Mulki SS, Tulasidas S. Changing antibiotic susceptibility pattern in uropathogenic Escherichia coli over a period of 5 years in a tertiary care center. Infection and Drug Resistance. 2019;12:1439.
18. Sanchez GV, Baird AMG, Karlowsky JA, Master RN, Bordon JM. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients. Journal of Antimicrobial Chemotherapy. 2014;69(12):3259-62.
19. Tulara NK. Nitrofurantoin and fosfomycin for extended spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae. Journal of global infectious diseases. 2018;10(1):19.
20. Patel B, Patel K, Shetty A, Soman R, Rodrigues C. Fosfomycin susceptibility in urinary tract Enterobacteriaceae. The Journal of the Association of Physicians of India. 2017;65(9):14-6.
21. Fajfr M, Louda M, Paterová P, Ryšková L, Pacovský J, Košina J, et al. The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study. BMC urology. 2017;17(1):1-6.
22. Mehrishi P, Faujdar SS, Kumar S, Solanki S, Sharma A. Antibiotic susceptibility profile of uropathogens in rural population of Himachal Pradesh, India: Where We are heading? Biomedical and Biotechnology Research Journal (BBRJ). 2019;3(3):171.
23. Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09. Journal of Antimicrobial Chemotherapy. 2014;69(1):234-40.
24. Chanda W, Manyepa M, Chikwanda E, Daka V, Chileshe J, Tembo M, et al. Evaluation of antibiotic susceptibility patterns of pathogens isolated from routine laboratory specimens at Ndola Teaching Hospital: A retrospective study. Plos one. 2019;14(12):e0226676.
25. Ali I, Shabbir M, Iman NU. Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups. JPMA. 2017;67(1161).
Copyright (c) 2021 Saima Naseem, Ambreen Fatima, Sahar Iqbal, Fatima Fasih, Syed Talha Naeem, Uzma Bukhari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All research articles published in the Journal of Rawalpindi Medical College (JRMC) are fully open access: immediately freely available to read, download, and share. Copyrights of all articles published in JRMC are retained by the authors. First publication rights are granted to JRMC. The journal/publisher is not responsible for subsequent uses of the work.
All articles are published under the Creative Commons Attribution (CC BY-SA 4.0) license.